Sarcopenia is a common clinical symptom in aging and patients with wasting diseases, characterized by a decreased skeletal muscle mass. As a consequence of lifestyle change, the nonalcoholic fatty liver disease (NAFLD) presents a rising trend. In the past three decades, increasing evidence has proved that sarcopenia is related to NAFLD. In this chapter, we will summarize the emerging evidence of the predictive role of sarcopenia in NAFLD and review the diagnosis value, feasible mechanism, and therapy strategies of sarcopenia in NAFLD. Sarcopenia is a potential risk factor for NAFLD, and targeting sarcopenia can benefit NAFLD to some extent.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/978-981-13-1435-3_19 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Relationship of the Degree of Sarcopenia with the Severity of Nonalcoholic Fatty Liver Disease and Cardiometabolic Risk in Adolescents.
Life (Basel)
November 2024
Department of Pediatrics, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam 13496, Republic of Korea.
The association between nonalcoholic fatty liver disease (NAFLD) and sarcopenia has been suggested. We investigated sarcopenia's impact on NAFLD severity and its relationship with cardiometabolic risk in adolescents. We conducted a retrospective study on 122 patients aged 13-18 years and diagnosed with both NAFLD and sarcopenia by laboratory tests, abdominal ultrasound (US), and multifrequency bioelectrical impedance analysis.
View Article and Find Full Text PDFDiagnosis and management of metabolic dysfunction- associated steatotic liver disease in South Asians- A clinical review.
Obes Pillars
December 2024
Department of Medicine, University of Connecticut, Farmington Avenue, Farmington, 06030, USA.
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD), previously termed as nonalcoholic fatty liver disease (NAFLD) is a hepatic manifestation of obesity and metabolic syndrome. It is mainly caused by insulin resistance. With the increased risk of visceral obesity in South Asians, the prevalence of MASLD is on the rise.
View Article and Find Full Text PDFClinical Characteristics of Sarcopenia in Nonalcoholic Fatty Liver Disease: A Systemic Scoping Review.
Obes Facts
October 2024
Center of Liver Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Article Synopsis
- * A total of 312 articles were screened, resulting in 9 studies being included, predominantly from Asian populations, which revealed trends such as older age, higher body mass index, and increased prevalence among women in those with both NAFLD and sarcopenia.
- * The review identifies the need for improved diagnostic criteria and emphasizes that more research is necessary to enhance early detection and management strategies for NAFLD patients who also have sarcopenia.
Liver at crossroads: unraveling the links between obesity, chronic liver diseases, and the mysterious obesity paradox.
Clin Exp Med
October 2024
Department of Hepatology and Gastroenterology, National Liver Institute, Menoufia University, Shebeen El-Kom, Egypt.
Obesity is a global health issue that is intricately linked to the development and progression of chronic liver disease (CLD). This bidirectional connection, coupled with the obesity paradox (OP), presents a management dilemma. The established influence of obesity on the development and progression of chronic liver disease (CLD) is surpassed by the liver's impact on the onset and advancement of obesity.
View Article and Find Full Text PDFBody Composition and Progression of Biopsy-Proven Non-Alcoholic Fatty Liver Disease in Patients With Obesity.
J Cachexia Sarcopenia Muscle
December 2024
Department of General Surgery, Division of Gastrointestinal Surgery, West China Hospital, Sichuan University, Chengdu, China.
Article Synopsis
- Obesity is a key factor in the progression of non-alcoholic fatty liver disease (NAFLD), but an effective non-invasive method to monitor its progression is currently unavailable.
- A study analyzed the relationship between CT-based body composition measurements and NAFLD progression, utilizing liver biopsies and evaluating patients' NAFLD activity scores (NAS).
- Results revealed that various body composition indicators, especially visceral fat index (VFI) and skeletal muscle indexes, are significantly related to NAFLD severity, highlighting the importance of monitoring these factors in obese patients.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!